Previous 10 | Next 10 |
NEW YORK, NY / ACCESSWIRE / October 5, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Cancer Genetics, Inc. (NASDAQ:CGIX) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Stemo...
NEW YORK, NY / ACCESSWIRE / September 24, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Bridge Bancorp, Inc. (NASDAQ:BDGE) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Dime Co...
NEW YORK, NY / ACCESSWIRE / September 17, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Immunomedics, Inc. (NASDAQ:IMMU) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Gilead Scienc...
NEW YORK, NY / ACCESSWIRE / September 12, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate: GCI Liberty, Inc. (NASDAQ:GLIBA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to...
RUTHERFORD, N.J., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced it will present at the 22 nd Annual Rodman & Renshaw Global Inves...
RUTHERFORD, N.J., and MAPLE GROVE, MN, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, and StemoniX, Inc., a company empowering the discovery of new medicines through the convergence o...
NEW YORK, NY / ACCESSWIRE / September 3, 2020 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating: Proteostasis Therapeutics, Inc. (NASDAQ: PTI) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to ...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . Stocks wrapped up another strong week on a high note, as the Federal Reserve’s new, more tolerant approach to inflation rippled t...
NEW YORK, Aug. 27, 2020 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may ultimately se...
Cancer Genetics (NASDAQ: CGIX ) -16% . More news on: Cancer Genetics, Inc., Smith & Wesson Brands, Inc., Sonnet BioTherapeutics Holdings, Inc., Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Cancer Genetics Inc. Company Name:
CGIX Stock Symbol:
NASDAQ Market:
Over the past decade, scientists have been exploring vaccination as a way to help fight cancer. These experimental cancer vaccines are designed to stimulate the body’s own immune system to destroy a tumor, by injecting fragments of cancer proteins found on the tumor. So far, none of the...
Cancer Genetics, Inc. Renamed to Vyant Bio, Inc. Vyant Bio, Inc. will begin trading on Nasdaq under the symbol VYNT CHERRY HILL, N.J., March 31, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company” or “CGI”) (Nasdaq: CGIX), an emerg...
Combined entity creates an innovative platform to de-risk and accelerate the discovery and development of preclinical and clinical pipelines with biopharma partners as well as the proprietary pipeline of the combined company RUTHERFORD, N.J., March 25, 2021 (GLOBE NEWSWIRE) ...